A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP
Clinical trial NCT04346654 · COMPLETED
Trial details
- NCT number
- NCT04346654
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-09
- Primary completion
- 2023-09-22
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.